Enorama Pharma AB OMXSTO:ERMA:
THE BALANCE SHEET FOR LIQUIDATION PURPOSES SHOWS THAT THE EQUITY IN ENORAMA PHARMA AB (PUBL) IS LESS THAN HALF OF THE REGISTERED SHARE CAPITAL
BOARD WILL CONVENE A FIRST CONTROL MEETING
REASON FOR NEGATIVE EQUITY IS UNIT ENORAMA PHARMA INC. NOT RECEIVING A REFUSE-TO-FILE DECISION FROM FDA REGARDING ITS APPLICATIONS FOR PRIOR APPROVAL OF TOBACCO PRODUCTS